Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5312017 | 1.00 | ZDHHC7 (0.43) | ZDHHC7CA2FAAHSMPD1ACE2 | |
| SCHEMBL6313962 | 1.00 | ZDHHC7 (0.43) | ZDHHC7CA2FAAHSMPD1ACE2 | |
| SCHEMBL18837208 | 0.89 | CA2 (0.40) | ZDHHC7CA2FAAHCA1CPB2 | |
| SCHEMBL157764 | 0.88 | NAAA (0.47) | ZDHHC7CA2FAAHSMPD1MAPT | |
| SCHEMBL2984689 | 0.88 | NAAA (0.47) | ZDHHC7CA2FAAHSMPD1MAPT | |
| SCHEMBL615494 | 0.88 | NAAA (0.47) | ZDHHC7CA2FAAHSMPD1MAPT | |
| SCHEMBL611992 | 0.88 | NAAA (0.47) | ZDHHC7CA2FAAHSMPD1MAPT | |
| SCHEMBL5918687 | 0.88 | NAAA (0.47) | ZDHHC7CA2FAAHSMPD1MAPT | |
| SCHEMBL5315110 | 0.88 | NAAA (0.47) | ZDHHC7CA2FAAHSMPD1MAPT | |
| SCHEMBL2961846 | 0.88 | NAAA (0.47) | ZDHHC7CA2FAAHSMPD1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118161520-A | Lipolytic composition using surface-modified gas-generating nanoparticles | 超新星生物有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-114828834-B | Lipolytic composition using surface-modified gas-generating nanoparticles | 超新星生物有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117297986-A | Cleaning cosmetic | 株式会社芳珂 | 2023-12-29 | — | — | CN | disclosed |
| US-20170105920-A1 | COSMETIC METHOD USING METAL PHTHALOCYANINE DERIVATIVE | DAIWABO NEU CO., LTD. (JP) | 2017-04-20 | — | — | US | disclosed |
| EP-2623092-A1 | COSMETIC COMPOSITION | l'Foret Co., Ltd. (JP) | 2013-08-07 | — | — | EP | disclosed |
| US-20130178508-A1 | COSMETIC COMPOSITION | Shirai, Hirofusa (JP) | 2013-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130178508-A1 | COSMETIC COMPOSITION | MITF, CUTA, SHH | ZDHHC7 828/4885CA2 827/4885FAAH 2744/4885 |
| US-20170105920-A1 | COSMETIC METHOD USING METAL PHTHALOCYANINE DERIVATIVE | GLA, CUTA, MITF | ZDHHC7 502/4885CA2 372/4885FAAH 3318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.